Annual Meeting Journalist Wrap-Up: Rapid Drug Development Benefiting Patients
Description: Academic researchers and the pharmaceutical industry often spend many years and millions of dollars researching new drugs. But what happens when a rare but serious disease has no treatment? That was the case for GIST in the year 2000. To solve the problem, researchers dedicated time to basic science research, to discover the biology of the disease and how it worked. This research led to three drugs developed and approved on the fast track within twelve short years. In this video, Oncology Times reporter Eric Rosenthal explains a new study that describes the approval process for the third and final drug recently approved and discusses how this research approach is generating a model for drug development in other cancers.
Shared By : patientpower
Posted on : 06/15/12
Added : 5 years ago